GIMI-IAOIP collaborates globally to address the challenges posed by the aging population crisis, mapping initiatives and innovations in brain health and longevity to reveal emerging trends and socioeconomic opportunities, underscoring the urgency of action in the face of  economic and health implications.

GIMI-IAOIP conducts an in-depth analysis of key players within the brain health industry, focusing on countries leading innovative efforts to prevent and address neurodegenerative diseases, including the USA, UK, Netherlands, Sweden, and Japan. Our research delves into the dynamic landscape of the neurodegenerative disease industry, identifying pivotal innovations that have transformed diagnosis, treatment, and disease management, ultimately enhancing patient outcomes.

GIMI-IAOIP and the National Innovation Centre Aging unite in a dynamic partnership to embark on a transformative journey and pioneer cutting-edge solutions for the world's aging population. The National Innovation Centre for Ageing ia a world-leading organization supported by an initial investment from UK Government and Newcastle University – to help co-develop and bring to market products and services which create a world in which we all live better, for longer.